{"id":682,"date":"2025-04-10T14:22:55","date_gmt":"2025-04-10T14:22:55","guid":{"rendered":"https:\/\/www.imvacs.org\/?page_id=682"},"modified":"2026-05-11T10:21:00","modified_gmt":"2026-05-11T10:21:00","slug":"news","status":"publish","type":"page","link":"https:\/\/www.imvacs.org\/fr\/news\/","title":{"rendered":"Actualit\u00e9s"},"content":{"rendered":"
<\/div><\/span>
\n

<\/p>\n\n\n\n

<\/div>\n\n\n\n

Actualit\u00e9s<\/h2>\n<\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n

<\/h2>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n
\n
IMVACS Clinical Trial Registration on PACTR<\/h5>\n\n\n\n

05 February 2025<\/em><\/p>\n\n\n\n

The IMVACS Clinical Trial has been successfully registered on the Pan African Clinical Trials Registry<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
\n
a new EVI clinical trial to protect pregnant women against malaria<\/h5>\n\n\n\n

EVI has launched a Phase II clinical trial in Mali to evaluate the R21 malaria vaccine in women of childbearing potential.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
\n
Data Safety Monitoring Board Set up & organizational meeting<\/h5>\n\n\n\n

31st March 2025<\/em><\/p>\n\n\n\n

The IMVACS Consortium held its initial organizational meeting with the newly appointed Data Safety Monitoring Board members.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

<\/h2>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n
\n
CoSAV-R21 trial<\/strong><\/h5>\n\n\n\n

In June 2025, Epicentre\/MSF in collaboration with other IMVACS partners, LSTM and CNRST, is about to launch the CoSAV-R21 trial in Chad.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
\n
Trial Steering Committee<\/h5>\n\n\n\n

30th April 2025<\/em><\/p>\n\n\n\n

IMVACS Consortium has officially set up its Trial Steering Committee.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
\n

Al-Sumait Prize <\/h2>\n\n\n\n

<\/p>\n\n\n\n

Professor Halidou Tinto from CNRST\/IRSS, one of the IMVACS key partners, won the prestigious Al-Sumait Prize<\/strong>.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n
\n
Prof. Tinto at Serum Institute of India<\/h5>\n\n\n\n

From June 1st to 4th, 2025, Professor Halidou Tinto visited the Serum Institute of India, in Pune, India.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/figure>\n\n\n\n
\n
<\/div>\n\n\n\n

IMVACS at ASTMH 2025<\/h2>\n\n\n\n

9-13th November<\/em><\/p>\n\n\n\n

Some members of our team proudly attended the ASTMH 2025 Annual Meeting<\/strong> in Toronto, Canada.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n
\n
World Children’s Day 2025<\/h5>\n\n\n\n
<\/div>\n\n\n\n

On 20th November 2025, the IMVACS Consortium celebrates the World Children’s Day. <\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n
\n
What strategy should be used to maximize the impact of the R21\/Matrix-M malaria vaccine?<\/h5>\n\n\n\n

A lesson from the CoSAV-R21 trial<\/strong><\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n
IMVACS at MSF Scientific <\/h5>\n\n\n\n
Day 2026<\/strong><\/h5>\n\n\n\n

Some partners from the IMVACS consortium will take part in the upcoming MSF Scientific Day on 20th May in London.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\n
<\/h5>\n\n\n\n
<\/div>\n\n\n\n

<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Pour en savoir plus<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>","protected":false},"excerpt":{"rendered":"

IMVACS Clinical Trial Registration on PACTR 05 February 2025 The IMVACS Clinical Trial has been successfully registered on the Pan African Clinical Trials Registry a new EVI clinical trial to protect pregnant women against malaria EVI has launched a Phase II clinical trial in Mali to evaluate the R21 malaria vaccine in women of childbearing […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-682","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t